Related Experiment Video
Updated: Feb 3, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Chronic interstitial lung diseases in children: diagnosis approaches
Nadia Nathan1,2, Laura Berdah1, Keren Borensztajn2
1a Service de pneumologie pédiatrique, Centre national de référence des maladies respiratoires rares RespiRare , Hôpital Armand Trousseau, Assistance Publique Hôpitaux de Paris (AP-HP) , Paris , France.
Insights
Children's interstitial lung disease (chILD) is a rare, complex group of lung disorders. This review updates on chILD pathophysiology, diagnosis, and genetic causes in immunocompetent children.
Area of Science:
- Pediatric Pulmonology
- Rare Respiratory Diseases
- Interstitial Lung Disease
Background:
- Children's interstitial lung disease (chILD) encompasses diverse rare respiratory disorders.
- These conditions involve inflammatory and fibrotic lung changes in children.
- chILD is categorized by etiology, including environmental, systemic, primary lung, and infant-specific types.
Purpose of the Study:
- To provide an updated review of chILD pathophysiology and diagnostic approaches in immunocompetent children.
- To discuss current knowledge regarding genetic causes of chILD.
- To highlight challenges in classification and the need for improved patient management and prognosis.
Main Methods:
- Literature review focusing on recent advancements in chILD research.
- Synthesis of information on pathophysiology, genetics, and diagnostic strategies.
- Analysis of current classifications and their limitations.
Main Results:
- chILD presents a broad spectrum of diseases with varied expressions.
- Recent genetic discoveries have identified some causative factors, but correlations with disease presentation are still lacking.
- Despite management improvements, chILD remains associated with significant morbidity and mortality.
Conclusions:
- International collaboration is crucial for building larger patient cohorts to advance chILD knowledge.
- Personalized care and structured genetic counseling are essential for affected families.
- The ultimate goal is to improve the transition to adulthood for children with chILD.
Abstract:
Introduction: Children interstitial lung disease (chILD) is a heterogeneous group of rare respiratory disorders characterized by inflammatory and fibrotic changes of the lung parenchyma. They include ILD related to exposure/environment insults, ILD related to systemic diseases processes, ILD related to primary lung parenchyma dysfunctions and ILD specific to infancy. Areas covered: This review provides an update on chILD pathophysiology and diagnosis approaches in immunocompetent children. It includes current information on genetic causes. Expert commentary: ChILD covers a large spectrum of entities with heterogeneous disease expression. Various classifications have been reported, but none of them seems completely satisfactory. Recently, progress in molecular genetics has allowed identifying some genetic contributors, with, so far, a lack of correlations between gene disorders and disease expression. Despite improvements in patient management, chILD prognosis is still burdened by significant morbidity and mortality. Ongoing international collaborations will allow gathering larger longitudinal cohorts of patients to improve disease knowledge and personalized care. The overall goal is to help the children with ILD to reach the adulthood transition in a better condition, and to structure genetic counseling for their family.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Kidney Disease II: Clinical Manifestations

